• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Group Behavior and Emergence of Cancer Drug Resistance.群体行为与癌症药物耐药性的出现
Trends Cancer. 2021 Apr;7(4):323-334. doi: 10.1016/j.trecan.2021.01.009. Epub 2021 Feb 20.
2
Drivers of dynamic intratumor heterogeneity and phenotypic plasticity.肿瘤内动态异质性和表型可塑性的驱动因素。
Am J Physiol Cell Physiol. 2021 May 1;320(5):C750-C760. doi: 10.1152/ajpcell.00575.2020. Epub 2021 Mar 3.
3
Leveraging Cancer Phenotypic Plasticity for Novel Treatment Strategies.利用癌症表型可塑性制定新型治疗策略。
J Clin Med. 2024 Jun 5;13(11):3337. doi: 10.3390/jcm13113337.
4
Understanding the role of phenotypic switching in cancer drug resistance.理解表型转换在癌症药物耐药性中的作用。
J Theor Biol. 2020 Apr 7;490:110162. doi: 10.1016/j.jtbi.2020.110162. Epub 2020 Jan 14.
5
Mass cytometry to decipher the mechanism of nongenetic drug resistance in cancer.采用质谱流式细胞术解析癌症中非遗传耐药机制。
Curr Top Microbiol Immunol. 2014;377:85-94. doi: 10.1007/82_2014_365.
6
Genotype- or Phenotype-Targeting Anticancer Therapies? Lessons from Tumor Evolutionary Biology.基因型靶向还是表型靶向抗癌疗法?肿瘤进化生物学的启示。
Curr Pharm Des. 2016;22(44):6625-6644. doi: 10.2174/1381612822666160831114002.
7
Modeling the chemotherapy-induced selection of drug-resistant traits during tumor growth.模拟肿瘤生长过程中化疗诱导的耐药性状选择。
J Theor Biol. 2018 Jan 7;436:120-134. doi: 10.1016/j.jtbi.2017.10.005. Epub 2017 Oct 13.
8
Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy.肺癌靶向治疗中肿瘤异质性和耐药机制的新见解。
J Hematol Oncol. 2019 Dec 9;12(1):134. doi: 10.1186/s13045-019-0818-2.
9
The role of memory in non-genetic inheritance and its impact on cancer treatment resistance.记忆在非遗传继承中的作用及其对癌症治疗耐药性的影响。
PLoS Comput Biol. 2021 Aug 30;17(8):e1009348. doi: 10.1371/journal.pcbi.1009348. eCollection 2021 Aug.
10
..
J Biosci. 2022;47.

引用本文的文献

1
Phenotypic Plasticity, Non-genetic Mechanisms, and Immune Drug Resistance in Cancer.癌症中的表型可塑性、非遗传机制与免疫耐药性
Cancer Treat Res. 2025;129:309-324. doi: 10.1007/978-3-031-97242-3_14.
2
Mathematical models of intercellular signaling in breast cancer.乳腺癌细胞间信号传导的数学模型
Semin Cancer Biol. 2025 Feb;109:91-100. doi: 10.1016/j.semcancer.2025.01.005. Epub 2025 Jan 29.
3
Role of TRIP13 in human cancer development.TRIP13 在人类癌症发展中的作用。
Mol Biol Rep. 2024 Oct 22;51(1):1088. doi: 10.1007/s11033-024-10012-x.
4
Exploring doxorubicin transport in 2D and 3D models of MDA-MB-231 sublines: impact of hypoxia and cellular heterogeneity on doxorubicin accumulation in cells.探索阿霉素在MDA-MB-231亚系的二维和三维模型中的转运:缺氧和细胞异质性对阿霉素在细胞中积累的影响。
Am J Cancer Res. 2024 Jul 15;14(7):3584-3599. doi: 10.62347/VNWH9165. eCollection 2024.
5
Increased prevalence of hybrid epithelial/mesenchymal state and enhanced phenotypic heterogeneity in basal breast cancer.基底样乳腺癌中上皮/间充质混合状态的患病率增加及表型异质性增强。
iScience. 2024 May 27;27(7):110116. doi: 10.1016/j.isci.2024.110116. eCollection 2024 Jul 19.
6
Leveraging Cancer Phenotypic Plasticity for Novel Treatment Strategies.利用癌症表型可塑性制定新型治疗策略。
J Clin Med. 2024 Jun 5;13(11):3337. doi: 10.3390/jcm13113337.
7
Editorial: Targeting nucleotide metabolism for enhancing antitumor immunity.社论:靶向核苷酸代谢以增强抗肿瘤免疫力。
Front Immunol. 2024 Apr 23;15:1412057. doi: 10.3389/fimmu.2024.1412057. eCollection 2024.
8
A Nexus between Genetic and Non-Genetic Mechanisms Guides KRAS Inhibitor Resistance in Lung Cancer.遗传和非遗传机制之间的联系指导肺癌中 KRAS 抑制剂耐药性。
Biomolecules. 2023 Oct 28;13(11):1587. doi: 10.3390/biom13111587.
9
Multi-modal transcriptomic analysis unravels enrichment of hybrid epithelial/mesenchymal state and enhanced phenotypic heterogeneity in basal breast cancer.多模态转录组分析揭示了基底型乳腺癌中混合上皮/间充质状态的富集以及表型异质性的增强。
bioRxiv. 2023 Oct 2:2023.09.30.558960. doi: 10.1101/2023.09.30.558960.
10
Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer.肺癌中通过遗传/非遗传机制获得对 KRAS G12C 小分子抑制剂的耐药性。
Sci Adv. 2023 Oct 13;9(41):eade3816. doi: 10.1126/sciadv.ade3816.

本文引用的文献

1
Cycling cancer persister cells arise from lineages with distinct programs.循环肿瘤干细胞由具有不同特性的细胞谱系产生。
Nature. 2021 Aug;596(7873):576-582. doi: 10.1038/s41586-021-03796-6. Epub 2021 Aug 11.
2
Persistence as an Optimal Hedging Strategy.作为一种最优套期保值策略的持久性
Biophys J. 2021 Jan 5;120(1):133-142. doi: 10.1016/j.bpj.2020.11.2260. Epub 2020 Nov 28.
3
Cancer Plasticity: The Role of mRNA Translation.癌症可塑性:mRNA 翻译的作用。
Trends Cancer. 2021 Feb;7(2):134-145. doi: 10.1016/j.trecan.2020.09.005. Epub 2020 Oct 13.
4
A machine learning Automated Recommendation Tool for synthetic biology.机器学习在合成生物学中的自动化推荐工具。
Nat Commun. 2020 Sep 25;11(1):4879. doi: 10.1038/s41467-020-18008-4.
5
A Non-genetic Mechanism Involving the Integrin β4/Paxillin Axis Contributes to Chemoresistance in Lung Cancer.一种涉及整合素β4/桩蛋白轴的非遗传机制导致肺癌化疗耐药。
iScience. 2020 Aug 22;23(9):101496. doi: 10.1016/j.isci.2020.101496. eCollection 2020 Sep 25.
6
Biological Networks Regulating Cell Fate Choice Are Minimally Frustrated.调控细胞命运选择的生物网络的最小阻碍。
Phys Rev Lett. 2020 Aug 21;125(8):088101. doi: 10.1103/PhysRevLett.125.088101.
7
MicroRNA-222 Regulates Melanoma Plasticity.微小RNA-222调控黑色素瘤可塑性。
J Clin Med. 2020 Aug 8;9(8):2573. doi: 10.3390/jcm9082573.
8
Ancient Evolutionary Origin of Intrinsically Disordered Cancer Risk Regions.内在无序的癌症风险区域的古老进化起源。
Biomolecules. 2020 Jul 28;10(8):1115. doi: 10.3390/biom10081115.
9
Cell plasticity in cancer cell populations.癌细胞群体中的细胞可塑性。
F1000Res. 2020 Jun 22;9. doi: 10.12688/f1000research.24803.1. eCollection 2020.
10
Circulating immune cell phenotype dynamics reflect the strength of tumor-immune cell interactions in patients during immunotherapy.循环免疫细胞表型动态反映了免疫治疗期间患者肿瘤-免疫细胞相互作用的强度。
Proc Natl Acad Sci U S A. 2020 Jul 7;117(27):16072-16082. doi: 10.1073/pnas.1918937117. Epub 2020 Jun 22.

群体行为与癌症药物耐药性的出现

Group Behavior and Emergence of Cancer Drug Resistance.

机构信息

Translational Bioinformatics, Center for Informatics, Department of Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA 91010, USA.

Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA 91010, USA.

出版信息

Trends Cancer. 2021 Apr;7(4):323-334. doi: 10.1016/j.trecan.2021.01.009. Epub 2021 Feb 20.

DOI:10.1016/j.trecan.2021.01.009
PMID:33622644
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8500356/
Abstract

Drug resistance is a major impediment in cancer. Although it is generally thought that acquired drug resistance is due to genetic mutations, emerging evidence indicates that nongenetic mechanisms also play an important role. Resistance emerges through a complex interplay of clonal groups within a heterogeneous tumor and the surrounding microenvironment. Traits such as phenotypic plasticity, intercellular communication, and adaptive stress response, act in concert to ensure survival of intermediate reversible phenotypes, until permanent, resistant clones can emerge. Understanding the role of group behavior, and the underlying nongenetic mechanisms, can lead to more efficacious treatment designs and minimize or delay emergence of resistance.

摘要

耐药性是癌症的主要障碍。虽然人们普遍认为获得性耐药性是由于基因突变引起的,但新出现的证据表明,非遗传机制也起着重要作用。耐药性通过异质性肿瘤内的克隆群体与周围微环境之间的复杂相互作用而出现。表型可塑性、细胞间通讯和适应性应激反应等特性协同作用,以确保中间可逆表型的存活,直到永久性耐药克隆能够出现。了解群体行为的作用和潜在的非遗传机制,可以导致更有效的治疗设计,并最小化或延迟耐药性的出现。